BUY Sanofi India Limited — Jefferies India
byJefferies IndiaHorizon: NA (inferred 1 year)28 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·24 Jul · 3mo ago
Q2 FY27 results scheduled — board meets 29 Oct 2026
NSE · Board Meeting·In 3 days
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·23 Oct · 2d ago
Sanofi India Limited has received a show cause notice from the GST authority.
NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·29 Sept · 4w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Sanofi India
- BUY — Sandeep Jain, Tradeswift24 Jul 2026 · ~1 year · target ₹4,000 · Active
- BUY — Kunal Saraogi24 Jun 2026 · ~1 year · target ₹5,500 · Active
More from Jefferies India
- BUY SAGILITY23 Oct 2026 · ~1 year · target ₹59 · Active
- BUY Colgate Palmolive (India)23 Oct 2026 · ~1 year · target ₹2,000 · Active
- BUY Swiggy23 Oct 2026 · ~1 year · target ₹330 · Active
- BUY JSW Infrastructure23 Oct 2026 · ~1 year · target ₹400 · Active
- BUY Vishal Mega Mart22 Oct 2026 · ~1 year · target ₹130 · Active

